These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 12582420)

  • 21. Presence of Epstein-Barr virus and human herpesvirus 6B DNA in multiple sclerosis patients: associations with disease activity.
    Höllsberg P; Kusk M; Bech E; Hansen HJ; Jakobsen J; Haahr S
    Acta Neurol Scand; 2005 Dec; 112(6):395-402. PubMed ID: 16281923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiviral therapy in children with hydroa vacciniforme.
    Lysell J; Wiegleb Edström D; Linde A; Carlsson G; Malmros-Svennilson J; Westermark A; Andersson J; Wahlgren CF
    Acta Derm Venereol; 2009; 89(4):393-7. PubMed ID: 19688153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistent productive Epstein-Barr virus replication in normal epithelial cells in vivo.
    Walling DM; Flaitz CM; Nichols CM; Hudnall SD; Adler-Storthz K
    J Infect Dis; 2001 Dec; 184(12):1499-507. PubMed ID: 11740724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.
    Loebel M; Eckey M; Sotzny F; Hahn E; Bauer S; Grabowski P; Zerweck J; Holenya P; Hanitsch LG; Wittke K; Borchmann P; Rüffer JU; Hiepe F; Ruprecht K; Behrends U; Meindl C; Volk HD; Reimer U; Scheibenbogen C
    PLoS One; 2017; 12(6):e0179124. PubMed ID: 28604802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of chronic fatigue in adolescents six months after acute Epstein-Barr virus infection: A prospective cohort study.
    Pedersen M; Asprusten TT; Godang K; Leegaard TM; Osnes LT; Skovlund E; Tjade T; Øie MG; Wyller VBB
    Brain Behav Immun; 2019 Jan; 75():94-100. PubMed ID: 30261303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Valacyclovir prevention of cytomegalovirus reactivation after heart transplantation: a randomized trial.
    Egan JJ; Carroll KB; Yonan N; Woodcock A; Crisp A
    J Heart Lung Transplant; 2002 Apr; 21(4):460-6. PubMed ID: 11927223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous measurement of antibodies to Epstein-Barr virus, human herpesvirus 6, herpes simplex virus types 1 and 2, and 14 enteroviruses in chronic fatigue syndrome: is there evidence of activation of a nonspecific polyclonal immune response?
    Manian FA
    Clin Infect Dis; 1994 Sep; 19(3):448-53. PubMed ID: 7811864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-viral prophylaxis reduces the incidence of lymphoproliferative disease in lung transplant recipients.
    Malouf MA; Chhajed PN; Hopkins P; Plit M; Turner J; Glanville AR
    J Heart Lung Transplant; 2002 May; 21(5):547-54. PubMed ID: 11983544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
    Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
    Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV-6 in post-infective fatigue syndrome.
    Cameron B; Flamand L; Juwana H; Middeldorp J; Naing Z; Rawlinson W; Ablashi D; Lloyd A
    J Med Virol; 2010 Oct; 82(10):1684-8. PubMed ID: 20827765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of prophylactic valacyclovir on the presence of human herpesvirus DNA in saliva of healthy individuals after dental treatment.
    Miller CS; Avdiushko SA; Kryscio RJ; Danaher RJ; Jacob RJ
    J Clin Microbiol; 2005 May; 43(5):2173-80. PubMed ID: 15872238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute retinal necrosis associated with Epstein-Barr virus: immunohistopathologic confirmation.
    Schaal S; Kagan A; Wang Y; Chan CC; Kaplan HJ
    JAMA Ophthalmol; 2014 Jul; 132(7):881-2. PubMed ID: 24743882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.
    Lowance D; Neumayer HH; Legendre CM; Squifflet JP; Kovarik J; Brennan PJ; Norman D; Mendez R; Keating MR; Coggon GL; Crisp A; Lee IC
    N Engl J Med; 1999 May; 340(19):1462-70. PubMed ID: 10320384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy.
    Kimberlin DF; Weller S; Whitley RJ; Andrews WW; Hauth JC; Lakeman F; Miller G
    Am J Obstet Gynecol; 1998 Oct; 179(4):846-51. PubMed ID: 9790357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A virologic pilot study of valacyclovir in infectious mononucleosis.
    Balfour HH; Hokanson KM; Schacherer RM; Fietzer CM; Schmeling DO; Holman CJ; Vezina HE; Brundage RC
    J Clin Virol; 2007 May; 39(1):16-21. PubMed ID: 17369082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and Efficacy of Antiviral Therapy for Prevention of Cytomegalovirus Reactivation in Immunocompetent Critically Ill Patients: A Randomized Clinical Trial.
    Cowley NJ; Owen A; Shiels SC; Millar J; Woolley R; Ives N; Osman H; Moss P; Bion JF
    JAMA Intern Med; 2017 Jun; 177(6):774-783. PubMed ID: 28437539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS.
    Bech E; Lycke J; Gadeberg P; Hansen HJ; Malmeström C; Andersen O; Christensen T; Ekholm S; Haahr S; Höllsberg P; Bergström T; Svennerholm B; Jakobsen J
    Neurology; 2002 Jan; 58(1):31-6. PubMed ID: 11781402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistence and transition of Epstein-Barr virus genotypes in the pathogenesis of oral hairy leukoplakia.
    Walling DM; Etienne W; Ray AJ; Flaitz CM; Nichols CM
    J Infect Dis; 2004 Jul; 190(2):387-95. PubMed ID: 15216477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr Virus dUTPase Induces Neuroinflammatory Mediators: Implications for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Williams PhD MV; Cox B; Lafuse PhD WP; Ariza ME
    Clin Ther; 2019 May; 41(5):848-863. PubMed ID: 31040055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serologic and virologic epidemiology of Epstein-Barr virus: relevance to chronic fatigue syndrome.
    Sumaya CV
    Rev Infect Dis; 1991; 13 Suppl 1():S19-25. PubMed ID: 1850540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.